X-Rx Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

X-Rx General Information

Description

Developer of a drug discovery platform intended to offer advanced small molecule medicines in inflammation, fibrosis, and oncology. The company's platform combines the power of DNA-encoded libraries with a virtual development model to discover novel therapeutics for difficult to treat diseases, enabling doctors to identify tractable blood cells.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 100 Beaver Street
  • Waltham, MA 02453
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

X-Rx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 00.00 Completed Out of Business
1. Early Stage VC (Series A) 04-Jan-2013 00.00 00.00 000.00 Completed Startup
To view X-Rx’s complete valuation and funding history, request access »

X-Rx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 000
To view X-Rx’s complete cap table history, request access »